Edition:
United Kingdom

Novan Inc (NOVN.OQ)

NOVN.OQ on NASDAQ Stock Exchange Global Market

2.57USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$2.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,757
52-wk High
$7.30
52-wk Low
$2.46

Chart for

About

Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's... (more)

Overall

Beta: --
Market Cap(Mil.): $85.83
Shares Outstanding(Mil.): 15.98
Dividend: --
Yield (%): --

Financials

  NOVN.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -2.85 -- --
ROI: -214.19 15.07 14.61
ROE: -- 16.60 16.33

BRIEF-Novan Provides Update On SB414 Inflammatory Skin Disease Development Program

* NOVAN PROVIDES UPDATE ON SB414 INFLAMMATORY SKIN DISEASE DEVELOPMENT PROGRAM

15 May 2018

BRIEF-Novan Interim CEO Kelly Martin Will No Longer Serve In Interim Capacity

* NOVAN ADVANCES ORGANIZATION AND STRENGTHENS LEADERSHIP TEAM

12 Apr 2018

BRIEF-Eugene Sun Appointed To Novan Board Of Directors

* EUGENE SUN APPOINTED TO NOVAN BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

21 Feb 2018

Earnings vs. Estimates